Eligible Study definition

Eligible Study means a Project to be studied that meets the eligibility criteria set out in Section 2 of Schedule "D" and is not a type of Project to be studied as described in Section 3 of Schedule "D".
Sample 1Sample 2Sample 3

Examples of Eligible Study in a sentence

  • X Class I: Eligible Study Abroad Student Participants and their Eligible Dependents enrolled in the Member’s sponsored or approved travel program who are temporarily traveling outside of the United States.

  • X Class II: Eligible Study Abroad Staff Participants and their Eligible Dependents providing direct support to the Member’s sponsored orapproved travel program who are temporarily traveling outside of the United States.The Insurer maintains its right to investigate eligibility, student status and attendance records, or employment records to verify that the eligibility requirements have been met.

  • X Class II: Eligible Study Abroad Staff Participants providing direct support to the Member’s sponsored or approved travel program who are temporarily traveling outside of the United States.The Insurer maintains its right to investigate eligibility, student status and attendance records, or employment records to verify that the eligibility requirements have been met.

  • The Planning and Development (Development Assessment Panels) Regulations 2011 (DAP Regulations) commenced on 24 March 2011.

  • Eligible Study AreasAny site or district located in a DRCOG community is eligible.

  • X Class II: Eligible Study Abroad Staff Participants and/or approved escort and their Eligible Dependents providing direct support to the Member’s sponsored or approved travel program who are temporarily traveling outside of the United States.The Insurer maintains its right to investigate eligibility, student status and attendance records, or employment records to verify that the eligibility requirements have been met.

  • This contract is between you and us for the work set out in these conditions and we will rely on this contract’s Terms and Conditions in providing your Annual Safety and Maintenance Inspection or Central Heating Care option 1 or option 2 and Boiler and Controls option 1 or option 2.

  • Included (n=24)Excluded (n=64) Unclear (n=10) Unfinished (n=13) Unrelated (n=41)Articles screened on title and abstract (n=88) Eligible Study (N = 15) Figure 1: Flowchart of a systematic search of papers with exclusion criteria used at each stage.

  • Eligible Study PopulationsEligible study populations differ by Network.

  • Maximum: 24 months + 4 months other kinds of leave (12 months at a time) Not Eligible Not Eligible Study Leave may be granted with due regard to the exigencies of public service to undergo, in or out of India, a special course of study consisting of higher studies or specialized training in a professional or a scientific or a technical subject having a direct and close connection with the sphere of duty- Rule 3 of Study Leave Rules under FR 84.

Related to Eligible Study

  • Eligible student means a student who is eighteen years or older.

  • Eligible State means, with respect to the Titling Trust, any State in which the Titling Trust is, if and to the extent required by Applicable Law, qualified, authorized and licensed to hold title or other evidence of the interest in leased vehicles.

  • Eligible school means an independent school including those religious in nature, other than a public school, at which the compulsory attendance requirements of Section 59-65-10 may be met, that:

  • Independent study means a subject/program/activity that a person pursues autonomously that meets standards for approval criteria in the rules and includes a posttest.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Eligible Service means service as an Independent Board Member.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Eligible Product means, instead of the definition in FAR 25.003—

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Examination Criteria means the loan classification criteria employed by, or any applicable regulations of, the Assuming Institution’s Chartering Authority at the time such action is taken, as such criteria may be amended from time to time.

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Eligible Shares has the meaning set forth in Section 4.1(a).

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Eligible patient means an individual who meets all of the following conditions:

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.